Answers are grounded in this paper and cite their sources.
170 million people worldwide are infected with chronic hepatitis c virus (HCV) [1]. There are an estimated 226700 people infected in Australia and it is the most common indication for liver transplantation in this country [2]. Despite this, overall treatment uptake remains low at <2% of patients infected undergoing treatment per year [3]. Rates of admission to hospital with decompensated liver cirrhosis are expected to increase by 190% by 2030 [4]. Cure of chronic HCV infection requires complex treatment regimens for several months.10.31579/2641-5194/021
No takes yet. Share an insight, caveat, or question.
Elliott et al. (2021) studied this question.
Synapse has enriched 8 related papers. Consider them for comparative context: